Insider Transactions in Q4 2021 at Arcutis Biotherapeutics, Inc. (ARQT)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 30
2021
|
Patrick Burnett Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,750
+38.95%
|
-
|
|
Dec 27
2021
|
Scott L Burrows Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
12,560
-35.64%
|
$251,200
$20.07 P/Share
|
|
Dec 23
2021
|
Howard G. Welgus Director |
SELL
Open market or private sale
|
Direct |
2,500
-1.36%
|
$50,000
$20.16 P/Share
|
|
Dec 23
2021
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+1.34%
|
$0
$0.58 P/Share
|
|
Dec 08
2021
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
1,000
-0.17%
|
$17,000
$17.0 P/Share
|
|
Dec 08
2021
|
Todd Franklin Watanabe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+0.17%
|
$1,000
$1.68 P/Share
|
|
Nov 05
2021
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
1,000
-0.17%
|
$21,000
$21.5 P/Share
|
|
Nov 05
2021
|
Todd Franklin Watanabe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+0.17%
|
$1,000
$1.68 P/Share
|
|
Nov 01
2021
|
Howard G. Welgus Director |
SELL
Open market or private sale
|
Direct |
2,500
-1.36%
|
$52,500
$21.81 P/Share
|
|
Nov 01
2021
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+1.34%
|
$0
$0.58 P/Share
|
|
Oct 05
2021
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
2,500
-0.42%
|
$60,000
$24.92 P/Share
|
|
Oct 05
2021
|
Todd Franklin Watanabe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+0.42%
|
$2,500
$1.68 P/Share
|
|
Oct 01
2021
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
1,500
-0.25%
|
$37,500
$25.01 P/Share
|
|
Oct 01
2021
|
Todd Franklin Watanabe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+0.25%
|
$1,500
$1.68 P/Share
|
|
Oct 01
2021
|
Howard G. Welgus Director |
SELL
Open market or private sale
|
Direct |
2,500
-1.36%
|
$57,500
$23.87 P/Share
|
|
Oct 01
2021
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+1.34%
|
$0
$0.58 P/Share
|